儿童急性肾损伤预防措施效果评价的Meta分析
结果显示右美托咪定可降低心脏手术或心脏造影术后患儿AKI风险,远端缺血预处理可降低心脏术后AKI风险,平衡盐溶液可降低脓毒症或脓毒性休克患儿AKI风险。
要点
- 右美托咪定可预防心脏手术或心脏造影术后患儿AKI。
- 远端缺血预处理可预防心脏术后患儿AKI。
- 平衡盐溶液可预防脓毒症或脓毒性休克患儿AKI。
核心结论
- 右美托咪定可降低心脏手术或心脏造影术后患儿AKI发生风险。
- 远端缺血预处理可降低心脏术后患儿AKI发生风险。
- 平衡盐溶液可降低脓毒症或脓毒性休克患儿AKI发生风险。
研究设计与样本
- 系统检索多个数据库及参考文献列表,纳入预防儿童AKI的随机对照试验,检索时间至2023年12月。
主要发现
- 右美托咪定预防心脏手术或心脏造影术后患儿AKI的OR=0.26、0.27(95%CI 0.11~0.64、0.13~0.58)。
- 远端缺血预处理预防心脏术后患儿AKI的OR=0.43、0.44(95%CI 0.24~0.79、0.23~0.83)。
- 平衡盐溶液预防脓毒症或脓毒性休克患儿AKI的OR=0.58、0.52(95%CI 0.42~0.79、0.37~0.73)。
- TSA显示右美托咪定(348例)和远端缺血预处理(666例)的总样本量均达到所需信息量(320、534例)。
- 平衡盐溶液的累积Z=3.38,穿越TSA监测边界Z=3.29。
关键数值与推荐
- 右美托咪定预防心脏手术或心脏造影术后患儿AKI:OR=0.26、0.27(95%CI 0.11~0.64、0.13~0.58)。
- 远端缺血预处理预防心脏术后患儿AKI:OR=0.43、0.44(95%CI 0.24~0.79、0.23~0.83)。
- 平衡盐溶液预防脓毒症或脓毒性休克患儿AKI:OR=0.58、0.52(95%CI 0.42~0.79、0.37~0.73)。
- TSA所需信息量:右美托咪定320例,远端缺血预处理534例。
临床怎么用
- 对于心脏手术或心脏造影术后患儿,可考虑使用右美托咪定预防AKI。
- 对于心脏术后患儿,可考虑采用远端缺血预处理预防AKI。
- 对于脓毒症或脓毒性休克患儿,可考虑使用平衡盐溶液预防AKI。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To comprehensively evaluate the effectiveness of preventive measures for acute kidney injury (AKI) in children and identify the effective strategies. Methods: Databases were systematically searched including CNKI, Wanfang, VIP, China Biology Medicine National Knowledge Infrastructure, PubMed, Embase, Cochrane Library databases, and the reference lists of relevant papers for randomized controlled trials on preventing pediatric AKI up to December 2023. Literature screening was conducted based on the inclusion and exclusion criteria, followed by data extraction and quality assessment of included studies. Traditional and network meta-analyses were performed, along with trial sequential analysis (TSA). Results: A total of 21 studies involving 3 483 children were included. Traditional and network meta-analysis showed that dexmedetomidine was effective in preventing AKI in children undergoing cardiac surgery or cardiac angiography (OR=0.26, 0.27; 95%CI 0.11-0.64, 0.13-0.58). Remote ischemic preconditioning (RIPC) was effective in preventing AKI in children after cardiac surgery (OR=0.43, 0.44; 95%CI 0.24-0.79, 0.23-0.83). Traditional and network meta-analysis specific to children with sepsis or septic shock showed that balanced solution was effective in preventing pediatric AKI (OR=0.58, 0.52; 95%CI 0.42-0.79, 0.37-0.73). TSA indicated that the total sample sizes of dexmedetomidine (348 cases) and RIPC (666 cases) both reached the required information size (320 and 534 cases); additionally, the Z-curve for balanced solution (cumulative Z=3.38) crossed the TSA monitoring boundary (Z=3.29). Conclusion: Dexmedetomidine reduces the risk of AKI in children undergoing cardiac surgery or cardiac angiography, RIPC decreases the risk of AKI in children after cardiac surgery, and balanced solution lowers the risk of AKI in children with sepsis or septic shock. 目的: 综合评估儿童急性肾损伤(AKI)的预防措施,找寻有效预防方案。 方法: 计算机检索中国知网、万方、维普、中国生物医学文献服务系统、PubMed、Embase、Cochrane Library数据库和相关文章参考文献列表,搜集预防儿童AKI的随机对照试验,时间限定为建库至2023年12月。按照纳入和排除标准筛选文献,对最终纳入文献进行数据提取和质量评价并进行传统和网状Meta分析和试验序贯分析(TSA)。 结果: 共纳入21项研究,包含3 483例患儿。传统Meta分析和网状Meta分析显示,右美托咪定可以有效预防心脏术后或心脏造影术后患儿的AKI(OR=0.26、0.27,95%CI 0.11~0.64、0.13~0.58),远端缺血预处理(RIPC)可以有效预防心脏术后患儿的AKI(OR=0.43、0.44,95%CI 0.24~0.79、0.23~0.83)。传统Meta分析和针对脓毒症或脓毒性休克患儿的网状Meta分析显示,平衡盐溶液可以有效预防儿童AKI(OR=0.58、0.52,95%CI 0.42~0.79、0.37~0.73)。TSA显示右美托咪定(348例)和RIPC(666例)的总样本量均达到所需信息量(320、534例),平衡盐溶液的Z值曲线(累积Z=3.38)穿越TSA监测边界(Z=3.29)。 结论: 右美托咪定可以降低心脏术后或心脏造影术后患儿群体AKI的发生风险,RIPC可以降低心脏术后患儿群体AKI的发生风险,平衡盐溶液可以降低脓毒症或脓毒性休克患儿群体AKI的发生风险。.
引用
- Hu JL, Li HW, Zhou YY, et al. [Meta-analysis of effectiveness evaluation of preventive measures for acute kidney injury in children]. Zhonghua Er Ke Za Zhi. 2024. PMID: 39192440. doi:10.3760/cma.j.cn112140-20240627-00443
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。